A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

NCT06233461 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
268
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Takeda